For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Neuromodulation is a process that makes use of an implantable medical device to modulate and alter neural activities for therapeutic purposes. Devices that are used for neuromodulation are called as neurostimulators or neurostimulation devices and usually function by bringing about stimulation of nerve impulses or by inhibition of pain signals produced at target sites that include autonomic nervous system, deep nuclei of the brain, peripheral nervous system, and central nervous system.
Scope of the Report:
This report focuses on the Neurosimulation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Neurosimulation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Boston Scientific
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Sacral Nerve Stimulators
- Spinal Cord Stimulators
- Gastric Electric Stimulators
- Deep Brain Stimulators
- Vagus Nerve Stimulators
Market Segment by Applications, can be divided into
- Pain Management
- Parkinson's Disease
There are 15 Chapters to deeply display the global Neurosimulation market.
Chapter 1, to describe Neurosimulation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Neurosimulation, with sales, revenue, and price of Neurosimulation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Neurosimulation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Neurosimulation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Neurosimulation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source